Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study

Health and Quality of Life Outcomes

Volumn 15, Issue 1, 2017, Pages

  Ludwig, Kristina ^a,b   von der Schulenburg, J Matthias Graf ^b   Greiner, Wolfgang ^a  

^a BIELEFELD UNIVERSITY   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Discrete choice experiment; EQ 5D 5L; Quality of life; Time trade off; Valuation

Indexed keywords

EXPLORATORY RESEARCH; FEASIBILITY STUDY; GERMAN (CITIZEN); GERMANY; HEALTH STATUS; HUMAN; INTERVIEW; MONITORING; POPULATION; QUALITY OF LIFE; ADULT; AGED; EVALUATION STUDY; FEMALE; MALE; MIDDLE AGED; QUESTIONNAIRE; SELF REPORT; STANDARDS; TIME FACTOR; YOUNG ADULT;

ADULT; AGED; FEMALE; GERMANY; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SELF REPORT; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 85013270034     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-017-0617-9     Document Type: Article

References (25)

1. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337-43.
2. Greiner W. Der EQ-5D der EuroQol-Gruppe. In: Schöffski O, Graf von der Schulenburg JM, editors. Gesundheitsökonomische Evaluationen. 4th ed. Berlin: Springer; 2012. p. 411-22.
3. Devlin NJ, Krabbe PFM. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14 Suppl 1:S1-3.
4. Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727-36.
5. Szende A, Oppe M, Devlin N. EQ-5D value sets: inventory, comparative review, and user guide. Dordrecht: Springer; 2007.
6. van Hout B, Janssen MF, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708-15.
7. Greiner W, Claes C, Busschbach JJV, Graf von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6:124-30.
8. Oppe M, Devlin NJ, van Hout B, Krabbe PFM, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17:445-53.
9. Shah K, Rand-Hendriksen K, Ramos JM, Prause AJ, Stolk E. Improving the quality of data collected in EQ-5D-5L valuation studies: a summary of the EQ-VT research methodology programme. In: Proceedings of the 31st Scientific Plenary Meeting of the EuroQol Group. 2014. p. 1-18.
10. Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. 2016. https://www.ohe.org/publications/valuing-health-related-quality-life-eq-5d-5l-value-set-england. Accessed 13 Jan 2017.
11. Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343-52.
12. Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N. EuroQol protocolsfor time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34:993-1004.
13. Ramos-Goñi JM, Oppe M, Slaap B, Busschbach JJV, Stolk E. Quality control process for EQ-5D-5L valuation studies. Value Health. 2016. doi: 10.1016/j.jval.2016.10.012.
14. Ramos-Goñi JM, Pinto-Prades JL, Oppe M, Cabasés JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5 L health states using a hybrid approach. Med Care. 2014. doi: 10.1097/MLR.0000000000000283.
15. Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA. Time trade-off: one methodology, different methods. Eur J Health Econ. 2013;14 Suppl 1:S53-64.
16. Devlin NJ, Tsuchiya A, Buckingham K, Tilling C. A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach. Health Econ. 2011;20:348-61.
17. Janssen BMF, Oppe M, Versteegh MM, Stolk EA. Introducing the composite time trade-off: a test of feasibility and face validity. Eur J Health Econ. 2013;14 Suppl 1:S5-13.
18. Bansback N, Brazier J, Tsuchiya A, Anis A. Using a discrete choice experiment to estimate health state utility values. J Health Econ. 2012;31:306-18.
19. Stolk EA, Oppe M, Scalone L, Krabbe PFM. Discrete choice modeling for the quantification of health states: the case of the EQ-5D. Value Health. 2010;13(8):1005-13.
20. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
21. Ramos-Goñi JM, Rand-Hendriksen K, Pinto-Prades JL. Does the introduction of the ranking task in valuation studies improve data quality and reduce inconsistencies? The case of the EQ-5D-5L. Value Health. 2016;19:478-86.
22. Stolk EA, Visser M, van Busschbach J. Test of two modifications of the EQ-VT to improve the consistency of TTO data. Stockholm; EuroQol Group. 2014.
23. Federal Statistical Office. Mikrozensus. Bevölkerung und Erwerbstätigkeit. Stand und Entwicklung der Erwerbstätigkeit in Deutschland 2014. Wiesbaden: Federal Statistical Office; 2015.
24. Feng Y, Devlin N, Shah K, Mulhern B, van Hout B. New methods for modelling EQ-5D-5L value sets: an application to English data. 2016. https://www.ohe.org/publications/newmethods-modelling-eq-5d-5l-value-sets-application-english-data. Accessed 13 Jan 2017.
25. Attema AE, Brouwer WBF. Deriving time discounting correction factors for TTO tariffs. Health Econ. 2014;23:410-25.